This editorial outlines a clinical approach to patients with periodic inflammation of unknown origin despite initial rational and targeted investigation. The focus of the editorial is on the recognition and diagnosis of systemic autoinflammatory diseases (SAIDs). Although rare, SAIDs are ...
It was a pleasure to discuss with Prof. Allan Klein (Cleveland Clinic, Cleveland, OH, USA) the results from the phase 3, RHAPSODY trial (NCT03737110) investigating the once-weekly IL-1α/IL-1β trap, rilonacept, in patients with recurrent pericarditis.
This information is brought to ...
Prof. Allan Klein (Cleveland Clinic, Cleveland, OH, USA) speaks to touchIMMUNOLOGY about recurrent pericarditis, the patient populations most frequently affected and current treatment options.
This information is brought to you by Touch Medical Media and is not sponsored by, nor ...
Login
Sign Up FREE
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Register now for FREE Access
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.